Lupin has declared its fourth quarter results. Kamal K Sharma, MD, Lupin says, the company’s endeavour would be to grow around 25% year-on-year (YoY) on organic basis, unless it makes some inorganic moves that could be additive. “Our attempt has always been to improve on EBITDA margins by atleast 75 bps,” he adds.
first published: May 12, 2011 04:27 pm
A collection of the most-viewed Moneycontrol videos.
Focused on building a bank that stakeholders will trust & admire
New Draft Rules 2026: Will your take-home salary increase?
IT Stocks Plunge Amid Renewed AI Worries; Nifty Tests 25,350 On F&O Expiry Day | Closing Bell Live
India, world in need of more power; KEC well poised in T&D segment : Anant Goenka
